These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7885933)

  • 1. Safety and diagnostic yield of noninvasive ventricular stimulation performed via tiered therapy implantable defibrillators.
    Pinski SL; Shewchick J; Tobin M; Castle LW
    Pacing Clin Electrophysiol; 1994 Dec; 17(12 Pt 1):2263-73. PubMed ID: 7885933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of noninvasive programmed stimulation for initiating ventricular tachyarrhythmias in patients with third-generation implantable cardioverter defibrillators.
    Kleiman RB; Callans DJ; Hook BG; Marchlinski FE
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1462-8. PubMed ID: 7991416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
    Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Clinical Experience With a New Automated Antitachycardia Pacing Algorithm: Feasibility and Safety in an Ambulatory Patient Cohort.
    Yee R; Fisher JD; Birgersdotter-Green U; Smith TW; Kenigsberg DN; Canby R; Jackson T; Taepke R; DeGroot P
    Circ Arrhythm Electrophysiol; 2017 Sep; 10(9):. PubMed ID: 28887360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate shock delivery by implantable defibrillators with dual chamber pacing during nonsustained ventricular tachycardia in patients with heart block.
    Sra J; Akhtar M
    Pacing Clin Electrophysiol; 2000 Jun; 23(6):1054-6. PubMed ID: 10879396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ventricular fibrillation versus monomorphic ventricular tachycardia during programmed stimulation. Role of premature beat conduction delay.
    Avitall B; McKinnie J; Jazayeri M; Akhtar M; Anderson AJ; Tchou P
    Circulation; 1992 Apr; 85(4):1271-8. PubMed ID: 1372847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
    Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
    Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
    Grimm W; Hoffmann J; Menz V; Luck K; Maisch B
    J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular fibrillation induction using nonsynchronized low energy external shock during rapid ventricular pacing: method of induction when fibrillation mode of ICD fails.
    Sanders WE; Hamrick GL; Herbst MC; Cascio WE; Simpson RJ; Wharton JM
    Pacing Clin Electrophysiol; 1996 Apr; 19(4 Pt 1):431-6. PubMed ID: 8848390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ventricular arrhythmias induced with programmed stimulation versus alternating current.
    Cua M; Veltri EP
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):382-6. PubMed ID: 7681187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term reproducibility of ventricular tachycardia induction in patients with implantable cardioverter/defibrillators. Serial noninvasive studies.
    Gillis AM; Sheldon RS; Wyse DG; Leitch JW; Yee R; Klein GJ; Duff HJ; Mitchell LB
    Circulation; 1995 May; 91(10):2605-13. PubMed ID: 7743623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequelae of nonsustained polymorphic ventricular tachycardia induced during programmed ventricular stimulation.
    Kou WH; de Buitleir M; Kadish AH; Morady F
    Am J Cardiol; 1989 Nov; 64(18):1148-51. PubMed ID: 2816767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
    Estes NA; Haugh CJ; Wang PJ; Manolis AS
    Am Heart J; 1994 Apr; 127(4 Pt 2):1038-46. PubMed ID: 8160578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.